Cargando…

Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH

Pulmonary arterial hypertension (PAH) is a rare disease that can be caused by (likely) pathogenic germline genomic variants. In addition to the most prevalent disease gene, BMPR2 (bone morphogenetic protein receptor 2), several genes, some belonging to distinct functional classes, are also now known...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eichstaedt, Christina A., Belge, Catharina, Chung, Wendy K., Gräf, Stefan, Grünig, Ekkehard, Montani, David, Quarck, Rozenn, Tenorio-Castano, Jair A., Soubrier, Florent, Trembath, Richard C., Morrell, Nicholas W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Task Force Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947314/ https://www.ncbi.nlm.nih.gov/pubmed/36302552 http://dx.doi.org/10.1183/13993003.01471-2022

Ejemplares similares

Task Force on Reintegration
Publicado: (1991)

Task Force on Reintegration Guarantees for the pensions of the CERN personnel in the event of the dissolution of the Organization Third Progress Report by the Chairman (Resolution Appendix 1)
Publicado: (1995)

Epidemiology and Financial Burden of Adult Chronic Hypoparathyroidism
por: Bjornsdottir, Sigridur, et al.
Publicado: (2022)

First Progress Report by the Chairman of the Task Force on Reintegration
Publicado: (1988)

Sustainable Development Goals and the Future of Cardiovascular Health: A Statement From the Global Cardiovascular Disease Taskforce
por: Zoghbi, William A., et al.
Publicado: (2014)

ESR/ERS white paper on lung cancer screening
por: Kauczor, Hans-Ulrich, et al.
Publicado: (2015)

IPS Task Force on Clinical Practice Guidelines Workshop held on Oct, 24, 25, 2015
Publicado: (2017)

IPS Task Force on Clinical Practice Guidelines Workshop held on Aug, 6 & 7, 2016
Publicado: (2017)

Digital health for the End TB Strategy: developing priority products and making them work
por: Falzon, Dennis, et al.
Publicado: (2016)

World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
por: Falzon, Dennis, et al.
Publicado: (2017)

Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC)
por: Ong, Catherine Wei Min, et al.
Publicado: (2020)

COVID-19: guidance on palliative care from a European Respiratory Society international task force
por: Janssen, Daisy J.A., et al.
Publicado: (2020)

Recommendations for respiratory syncytial virus surveillance at the national level
por: Teirlinck, Anne C., et al.
Publicado: (2021)

World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
por: Mirzayev, Fuad, et al.
Publicado: (2021)

Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis
Publicado: (2022)

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
por: Agustí, Alvar, et al.
Publicado: (2023)

The COVID-19 reset: lessons from the pandemic on Burnout and the Practice of Surgery
por: Romanelli, John, et al.
Publicado: (2020)

Non-Amyloid Approaches to Disease Modification for Alzheimer’s Disease: An EU/US CTAD Task Force Report
por: Gauthier, Serge, et al.
Publicado: (2020)

Appetite Loss and Anorexia of Aging in Clinical Care: An ICFSR Task Force Report
por: de Souto Barreto, Philipe, et al.
Publicado: (2022)

Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
por: Cesari, Matteo, et al.
Publicado: (2022)

Platform Trials to Expedite Drug Development in Alzheimer’s Disease: A Report from the EU/US CTAD Task Force
por: Aisen, P. S., et al.
Publicado: (2021)

Using Digital Tools to Advance Alzheimer’s Drug Trials During a Pandemic: The EU/US CTAD Task Force
por: Kaye, Jeffrey, et al.
Publicado: (2021)

Tackling a Major Deficiency of Diversity in Alzheimer’s Disease Therapeutic Trials: An CTAD Task Force Report
por: Raman, Rema, et al.
Publicado: (2022)

Allergic and hypersensitivity conditions in non‐specialist care: Flow diagrams to support clinical practice
por: Ryan, Dermot, et al.
Publicado: (2022)

Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation
por: Moeller, Alexander, et al.
Publicado: (2015)

Monitoring asthma in childhood: symptoms, exacerbations and quality of life
por: Brand, Paul L.P., et al.
Publicado: (2015)

Monitoring asthma in childhood: management-related issues
por: Rottier, Bart L., et al.
Publicado: (2015)

Introduction
por: Whitby, Karen E., et al.
Publicado: (1987)

European Union Standards for Tuberculosis Care
por: Migliori, G.B., et al.
Publicado: (2012)

Clinical Practice Guidelines
Publicado: (2017)

Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations
por: Swinnen, Katleen, et al.
Publicado: (2019)

Pulmonary arterial hypertension drugs can partially restore altered angiogenic capacities in bmpr2‐silenced human lung microvascular endothelial cells
por: Tielemans, Birger, et al.
Publicado: (2023)

Incremental Experience in In Vitro Primary Culture of Human Pulmonary Arterial Endothelial Cells Harvested from Swan-Ganz Pulmonary Arterial Catheters
por: Tielemans, Birger, et al.
Publicado: (2021)

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
por: Belge, Catharina, et al.
Publicado: (2020)

Does Targeted Education of Emergency Physicians Improve Their Comfort Level in Treating Psychiatric Patients?
por: Marciano, Reetta, et al.
Publicado: (2012)

Factors Affecting Candidate Placement on an Emergency Medicine Residency Program’s Rank Order List
por: Breyer, Michael J., et al.
Publicado: (2012)

Cytokines trigger disruption of endothelium barrier function and p38 MAP kinase activation in BMPR2-silenced human lung microvascular endothelial cells
por: Tielemans, Birger, et al.
Publicado: (2019)

Right Heart Size and Right Ventricular Reserve in Pulmonary Hypertension: Impact on Management and Prognosis
por: Grünig, Ekkehard, et al.
Publicado: (2020)

Genetics and genomics of pulmonary arterial hypertension
por: Morrell, Nicholas W., et al.
Publicado: (2019)

Mutually reinforcing effects of genetic variants and interferon-β 1a therapy for pulmonary arterial hypertension development in multiple sclerosis patients
por: Lerche, Marianne, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_58bkkj47dhce05i8udjb4im7pd